Production (Stage)
Avidity Biosciences, Inc.
RNA
$33.60
$2.156.82%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 50.66% | 152.20% | 192.78% | 125.33% | 56.21% |
| Total Receivables | 304.67% | 227.29% | 1,821.00% | 1,228.32% | 804.00% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 93.66% | 71.43% | 18.14% | 27.76% | -2.90% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 53.56% | 152.29% | 191.97% | 123.50% | 56.49% |
|
|
|||||
| Total Current Assets | 53.56% | 152.29% | 191.97% | 123.50% | 56.49% |
| Net Property, Plant & Equipment | 26.33% | 9.83% | -7.31% | -0.42% | 1.09% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 390.83% | 456.38% | 387.17% | 339.36% | -0.69% |
| Total Assets | 53.35% | 148.81% | 186.27% | 120.61% | 54.97% |
|
|
|||||
| Total Accounts Payable | 182.38% | -3.95% | 38.05% | 57.24% | -39.89% |
| Total Accrued Expenses | 41.13% | 62.35% | 60.14% | 37.48% | 18.85% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.24% | 5.63% | 5.61% | 19.49% | 19.08% |
| Total Finance Division Other Current Liabilities | -46.45% | -26.01% | 898.98% | 600.71% | 416.18% |
| Total Other Current Liabilities | -46.45% | -26.01% | 898.98% | 600.71% | 416.18% |
| Total Current Liabilities | 13.22% | 21.49% | 87.48% | 86.13% | 55.88% |
|
|
|||||
| Total Current Liabilities | 13.22% | 21.49% | 87.48% | 86.13% | 55.88% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -61.45% | -52.41% | -45.59% | -27.43% | -22.29% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 7.96% | -7.18% | -- | -- | -- |
| Total Liabilities | 8.11% | 8.72% | 146.68% | 144.91% | 118.98% |
|
|
|||||
| Common Stock & APIC | 58.72% | 116.08% | 122.12% | 89.44% | 51.43% |
| Retained Earnings | -57.72% | -56.47% | -54.96% | -55.12% | -55.65% |
| Treasury Stock & Other | 696.12% | 2,221.60% | 478.17% | 83.01% | 69.65% |
| Total Common Equity | 59.91% | 184.56% | 190.53% | 118.36% | 48.66% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 59.91% | 184.56% | 190.53% | 118.36% | 48.66% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 59.91% | 184.56% | 190.53% | 118.36% | 48.66% |
|
|
|||||